+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Organic Pharmaceutical Excipients Market by Product Type, Application, Form, Source - Global Forecast to 2030- Product Image
Organic Pharmaceutical Excipients Market by Product Type, Application, Form, Source - Global Forecast to 2030- Product Image
Sale

Organic Pharmaceutical Excipients Market by Product Type, Application, Form, Source - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4807793
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Organic pharmaceutical excipients are increasingly recognized as mission-critical components in modern drug development strategies. Senior decision-makers should monitor this market as shifts in regulation, technology, and sustainability continue to transform product performance standards and supply chain stability.

Market Snapshot: Organic Pharmaceutical Excipients Market

The Organic Pharmaceutical Excipients Market grew from USD 12.52 billion in 2024 to USD 13.80 billion in 2025. It is expected to continue growing at a CAGR of 9.85%, reaching USD 22.01 billion by 2030. This robust momentum is underpinned by greater regulatory scrutiny, the rise of biologics, and increasing demand for excipient purity and traceability. The market's trajectory reflects expanding applications across dosage forms as well as intensifying competition among both established global suppliers and agile regional producers.

Scope & Segmentation

This report provides strategic guidance by clarifying the full landscape of the organic pharmaceutical excipients market across product types, applications, forms, sources, regions, and leading companies.

  • Product Types: Cellulose derivatives (including hydroxypropyl methylcellulose and microcrystalline cellulose), gelatin, inorganic salts (such as calcium phosphate and magnesium stearate), starches and dextrins (corn starch, potato starch), sugars and polymers (lactose, mannitol, sucrose)
  • Applications: Injectable, ophthalmic, oral solid dosage (capsules, tablets), topical
  • Forms: Gel, granule, liquid, powder
  • Sources: Natural, semi-synthetic, synthetic
  • Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—plus Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, and other key nations); Asia-Pacific (China, India, Japan, Australia, South Korea, several Southeast Asian countries)
  • Key Companies: Roquette Frères, Ashland Global Holdings, Croda International, BASF, Evonik Industries, Kerry Group, International Flavors & Fragrances, JRS Pharma, DFE Pharma, Ingredion Incorporated

Key Takeaways for Senior Decision-Makers

  • Organic excipients are now pivotal in enhancing drug stability, enabling controlled release, supporting novel delivery mechanisms, and improving patient acceptability.
  • Market drivers include heightened regulatory expectations related to sustainability, traceability, and impurity reduction, which have elevated excipients from commodities to strategic assets.
  • Technologies such as process analytical technology and digital twin modeling are improving production consistency, reducing variability, and supporting more efficient manufacturing practices for premium excipient grades.
  • Innovative functionalities—including high-purity carriers and advanced polymer chemistries—support emerging therapeutic modalities and increasing demand for patient-centric dosage forms.
  • Regional markets vary in maturity, with the Americas benefiting from advanced regulatory regimes, Europe, Middle East & Africa advancing sustainability mandates, and Asia-Pacific focusing on cost-effective expansion and domestic capacity building.
  • Industry consolidation, partnerships, and direct collaboration with formulators and biotechs are reshaping competitive differentiation focused on both innovation and sustainability objectives.

Tariff Impact on Supply Chains

New tariffs imposed by the United States in 2025 on certain organic excipients have realigned global sourcing strategies. Manufacturers are reassessing procurement to mitigate cost volatility and supply risks. Some have shifted orders away from impacted regions or expanded domestic capacity, while others are strengthening contingency plans through supplier diversification and in-house manufacturing. These moves reinforce the imperative for supply chain agility in light of policy-driven cost and regulatory pressures.

Methodology & Data Sources

Findings are grounded in a mixed-method approach encompassing interviews with key stakeholders across global markets, comprehensive review of scientific and regulatory sources, and proprietary analysis of trade and customs data. Quality assurance incorporated triangulation and cross-validation through expert peer review, ensuring that conclusions reflect timely and reliable market insight.

Why This Report Matters

  • Gain actionable intelligence to anticipate regulatory and environmental changes impacting excipient procurement, sourcing, and innovation portfolios.
  • Benchmark competitors and segment strategies to inform targeted investment and partnership decisions in a complex, fast-evolving global context.

Conclusion

The organic pharmaceutical excipients market is transforming in response to regulatory, technological, and geographic shifts. Strategic adaptation to these evolving trends is essential for maintaining a resilient and competitive portfolio in the years ahead.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Organic Pharmaceutical Excipients Market, by Product Type
8.1. Introduction
8.2. Cellulose Derivatives
8.2.1. Hydroxypropyl Methylcellulose
8.2.2. Microcrystalline Cellulose
8.3. Gelatin
8.4. Inorganic Salts
8.4.1. Calcium Phosphate
8.4.2. Magnesium Stearate
8.5. Starches and Dextrins
8.5.1. Corn Starch
8.5.2. Potato Starch
8.6. Sugars and Polymers
8.6.1. Lactose
8.6.2. Mannitol
8.6.3. Sucrose
9. Organic Pharmaceutical Excipients Market, by Application
9.1. Introduction
9.2. Injectable
9.3. Ophthalmic
9.4. Oral Solid Dosage
9.4.1. Capsules
9.4.2. Tablets
9.5. Topical
10. Organic Pharmaceutical Excipients Market, by Form
10.1. Introduction
10.2. Gel
10.3. Granule
10.4. Liquid
10.5. Powder
11. Organic Pharmaceutical Excipients Market, by Source
11.1. Introduction
11.2. Natural
11.3. Semi Synthetic
11.4. Synthetic
12. Americas Organic Pharmaceutical Excipients Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Organic Pharmaceutical Excipients Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Organic Pharmaceutical Excipients Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roquette Frères S.A.
15.3.2. Ashland Global Holdings Inc.
15.3.3. Croda International Plc
15.3.4. BASF SE
15.3.5. Evonik Industries AG
15.3.6. Kerry Group Plc
15.3.7. International Flavors & Fragrances Inc.
15.3.8. JRS Pharma GmbH & Co. KG
15.3.9. DFE Pharma International Ltd.
15.3.10. Ingredion Incorporated
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET MULTI-CURRENCY
FIGURE 2. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET MULTI-LANGUAGE
FIGURE 3. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MAGNESIUM STEARATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CORN STARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POTATO STARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GRANULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEMI SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 64. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 65. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 66. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 67. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 69. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 70. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 117. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 119. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 121. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 128. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 130. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 131. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 133. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 134. FRANCE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 144. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 146. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 147. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 148. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 149. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 151. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 152. ITALY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 155. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 156. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 157. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 158. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 160. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 161. SPAIN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 189. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 191. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 193. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 194. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 196. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. DENMARK ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 207. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 209. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 210. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 211. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 212. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 214. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 215. QATAR ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 216. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 218. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 220. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 224. FINLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 243. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 245. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 247. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 248. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 250. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 251. EGYPT ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 252. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 254. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 255. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 256. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 257. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 259. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 260. TURKEY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 270. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 272. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 274. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 275. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 279. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 281. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 282. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 283. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 284. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 286. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 287. POLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Organic Pharmaceutical Excipients market report include:
  • Roquette Frères S.A.
  • Ashland Global Holdings Inc.
  • Croda International Plc
  • BASF SE
  • Evonik Industries AG
  • Kerry Group Plc
  • International Flavors & Fragrances Inc.
  • JRS Pharma GmbH & Co. KG
  • DFE Pharma International Ltd.
  • Ingredion Incorporated

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 13.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.01 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pharmaceutical Excipient Market by Type, Formulation, Function, End-User - Global Forecast to 2030 - Product Image

Pharmaceutical Excipient Market by Type, Formulation, Function, End-User - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Binders Excipients Market by Type, Application, Form, Grade - Global Forecast to 2030 - Product Image

Binders Excipients Market by Type, Application, Form, Grade - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Organic Pharmaceutical Excipients Market Report 2025 - Product Image

Organic Pharmaceutical Excipients Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Excipients in Pharmaceuticals: Global Markets to 2029 - Product Image

Excipients in Pharmaceuticals: Global Markets to 2029

  • Report
  • 105 Pages
  • Global
From
Pharmaceutical Excipients - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Pharmaceutical Excipients - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Organic Pharmaceutical Excipient Market

Organic Pharmaceutical Excipients are substances used in the production of pharmaceuticals to provide stability, improve bioavailability, and enhance the delivery of active ingredients. They are used in the manufacture of tablets, capsules, and other dosage forms. Excipients are also used to improve the taste, texture, and appearance of pharmaceuticals. They are typically derived from natural sources such as plants, animals, and minerals. Organic Pharmaceutical Excipients are an important part of the Pharmaceutical Intermediates market. They are used to improve the quality and safety of pharmaceuticals, and to ensure that they meet regulatory requirements. Excipients are also used to improve the shelf life of pharmaceuticals, and to reduce the cost of production. Some companies in the Organic Pharmaceutical Excipient market include BASF, Roquette, Ashland, Croda, and Lubrizol. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.